Cite
Jones DA, Wright P, Alizadeh MA, et al. The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction. Eur Heart J Cardiovasc Pharmacother. 2021;7(5):398-404doi: 10.1093/ehjcvp/pvaa096.
Jones, D. A., Wright, P., Alizadeh, M. A., Fhadil, S., Rathod, K. S., Guttmann, O., Knight, C., Timmis, A., Baumbach, A., Wragg, A., Mathur, A., & Antoniou, S. (2021). The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction. European heart journal. Cardiovascular pharmacotherapy, 7(5), 398-404. https://doi.org/10.1093/ehjcvp/pvaa096
Jones, Daniel A, et al. "The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction." European heart journal. Cardiovascular pharmacotherapy vol. 7,5 (2021): 398-404. doi: https://doi.org/10.1093/ehjcvp/pvaa096
Jones DA, Wright P, Alizadeh MA, Fhadil S, Rathod KS, Guttmann O, Knight C, Timmis A, Baumbach A, Wragg A, Mathur A, Antoniou S. The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction. Eur Heart J Cardiovasc Pharmacother. 2021 Sep 21;7(5):398-404. doi: 10.1093/ehjcvp/pvaa096. PMID: 32730627.
Copy
Download .nbib